Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
about
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentinDiagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature reviewCitrullination, a possible functional link between susceptibility genes and rheumatoid arthritisAnti-Sa antibodies: prognostic and pathogenetic significance to rheumatoid arthritisAutoantibodies in normals--the value of predicting rheumatoid arthritisThe role and clinical implications of G6PI in experimental models of rheumatoid arthritisCitrullinated proteins: sparks that may ignite the fire in rheumatoid arthritisAdvanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitisAmplification of autoimmune disease by infectionInsights into rheumatoid arthritis derived from the Sa immune system.A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritisAutoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic valueIdentification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritisCitrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severityAnti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.Therapeutic implications of autoantibodies in rheumatoid arthritisAnti-cyclic citrullinated peptide antibodies in psoriatic arthritis--cross-sectional study and literature reviewClinical biomarkers and pathogenic-related cytokines in rheumatoid arthritisMolecular Interactions Governing Autoantigen Presentation in Type 1 DiabetesPresenting features of polymyalgia rheumatica (PMR) and rheumatoid arthritis with PMR-like onset: a prospective studyAccumulation of plasma cells expressing CXCR3 in the synovial sublining regions of early rheumatoid arthritis in association with production of Mig/CXCL9 by synovial fibroblasts.Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in tERK-dependent T cell receptor threshold calibration in rheumatoid arthritis.Roles of B cells in rheumatoid arthritisAntibodies against cyclic citrullinated peptides in infectious diseases--a systematic review.Early rheumatoid arthritis: can we predict its outcome?Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis.Insights from populations at risk for the future development of classified rheumatoid arthritisAnti-citrulline antibodies in the diagnosis and prognosis of rheumatoid arthritis: evolving concepts.Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis.Why do we not have a cure for rheumatoid arthritis?Autoantibodies in rheumatoid arthritis and their clinical significance.Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.N-α-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis.Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis.Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritisPerformance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis.Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.
P2860
Q21195679-FD304132-476F-47CF-8BAE-E7EBCEE396C4Q24675281-1148403E-3BEA-4ADC-89C9-5F39A6ABCC00Q24793137-D3F12717-9AB9-4A7E-874C-D41C133270DDQ24793853-B98D1245-BF0D-4A76-BB98-2A3CAA42F26CQ24798609-2DD3495F-BC1D-42FA-B492-F57C92E936C1Q24799403-40A1BB56-6EB2-4AF0-8FA1-74A5E66C4B5CQ24801080-31688BEF-1B6C-42CA-9A71-DE0B7F5D3087Q24804160-B15383B9-2E2B-44BD-B744-AD1B2CA59BC8Q24804390-5242BE22-B6A2-41BC-9B0F-1DCE8AE0AF7CQ24805044-20EAE071-DD3C-4C9C-82E3-3623AD221AABQ24805387-F55E7FF3-8693-45F9-ADA5-E748DF480357Q24806041-6E92E8EB-5D7D-43D1-8FBB-B2A62F84E6F4Q24813085-B9E917E5-873E-4369-878D-7CDD2330F340Q24816615-BAABDDDE-F415-4D6C-9C1E-C2076FF05351Q24816803-A602884A-A9A5-4EF7-8CB9-A74C1FB1B83DQ26744033-D73EEDF3-015A-4ED1-B330-BADAD1BB3791Q27001098-578225DD-9D9D-4CB7-A8DC-3D71E297638FQ27022559-049FC13A-7CBD-45E9-BEB1-41CAD3A2EA39Q28084487-FE1F8D15-655F-441F-B91F-AE749F64822DQ28361773-234D8C8B-5E70-419E-9764-EF83BC3B97E8Q30790246-6197B9E4-08E6-4722-9488-862B6339B601Q33322989-5B36CA27-E3AD-44D6-AB1D-8764C7453FA8Q33665938-E7090A1C-10A9-471E-A4C0-34DC73DF72B0Q33686997-F81EC246-E4C0-4BB0-BFCE-27F86F64CBE2Q33708839-0E8242DA-6595-454D-90AC-8A03E28A4160Q34129802-71647CF9-37A6-4740-8A4F-E9D733A432E9Q34322390-D4859C17-1445-4C6F-A0CF-B0CE831672E9Q34367709-3A13242B-E88A-47D8-85C3-B99FB10C9314Q34604615-AC400645-45C3-4FE4-9DAF-F18385315E88Q34635933-B8ADECF0-ADC1-4AC3-8736-C8E22B6D35CAQ34650192-42AFAA56-7E5E-48A0-AF77-D57FA979CA07Q34731262-5265F1A8-6DBE-47A1-BE94-E52148AADB12Q34731269-07B79BF3-0111-49FC-99BC-8BEA93941D30Q34896320-6105548E-199C-4D30-A2E4-2EA8C4CCF266Q34904630-8268DFA7-FF6F-4DFF-96F0-0E1E90A6D766Q34917019-6B048CB2-90F5-4283-A878-39F037E568EBQ35177819-6D571F20-8171-4F66-8E09-6E062A443987Q35550790-27116057-3009-4E0A-AC04-A533E2B14FDBQ35551700-2FAE3909-3B1D-4D8F-9C74-6C31FF8793D8Q35552357-49DB842E-0042-4E10-90F7-86911E87657A
P2860
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
description
2000 nî lūn-bûn
@nan
2000 թուականին հրատարակուած գիտական յօդուած
@hyw
2000 թվականին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@ast
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@en
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@nl
type
label
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@ast
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@en
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@nl
prefLabel
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@ast
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@en
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@nl
P2093
P2860
P3181
P356
P1476
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset
@en
P2093
H A Ménard
H R Schumacher
H S El-Gabalawy
J H Klippel
J Hoxworth
P2860
P2888
P304
P3181
P356
10.1186/AR93
P407
P577
2000-01-01T00:00:00Z
P5875
P6179
1019461231